{"id": "fv9XU7CyN2", "round": 0, "round_best": "Develop a contrastive learning framework that integrates multimodal molecular data, including chemical structure, genomic data, and metabolic pathways, to discover novel antibiotic compounds. This model could use unsupervised learning to identify latent representations that differentiate effective antibiotics from non-effective compounds across different bacterial species. By highlighting subtle molecular differences that correlate with antibiotic potency and spectrum of activity, this approach could prioritize compounds for synthesis and testing that are likely to be effective against resistant bacterial strains.", "round_best_score": 0.82, "best_so_far": "Develop a contrastive learning framework that integrates multimodal molecular data, including chemical structure, genomic data, and metabolic pathways, to discover novel antibiotic compounds. This model could use unsupervised learning to identify latent representations that differentiate effective antibiotics from non-effective compounds across different bacterial species. By highlighting subtle molecular differences that correlate with antibiotic potency and spectrum of activity, this approach could prioritize compounds for synthesis and testing that are likely to be effective against resistant bacterial strains.", "best_score_so_far": 0.82, "#explored_so_far": 0, "#cands_this_round": 0}
{"id": "fv9XU7CyN2", "round": 1, "round_best": "Integrate advanced graph neural networks with the contrastive learning framework to model the complex relationships between molecular structures and their biological functions. This could help in better capturing the non-linear interactions within multimodal molecular data, thereby improving the identification and prediction of novel antibiotic candidates.", "round_best_score": 0.75, "best_so_far": "Develop a contrastive learning framework that integrates multimodal molecular data, including chemical structure, genomic data, and metabolic pathways, to discover novel antibiotic compounds. This model could use unsupervised learning to identify latent representations that differentiate effective antibiotics from non-effective compounds across different bacterial species. By highlighting subtle molecular differences that correlate with antibiotic potency and spectrum of activity, this approach could prioritize compounds for synthesis and testing that are likely to be effective against resistant bacterial strains.", "best_score_so_far": 0.82, "#explored_so_far": 8, "#cands_this_round": 8}
{"id": "fv9XU7CyN2", "round": 2, "round_best": "Apply graph neural networks within the contrastive learning framework to better capture the complex interactions between molecular components. This could improve the model's ability to discern subtle structural variations in molecules that are crucial for the development of antibiotics with novel mechanisms of action.", "round_best_score": 0.72, "best_so_far": "Develop a contrastive learning framework that integrates multimodal molecular data, including chemical structure, genomic data, and metabolic pathways, to discover novel antibiotic compounds. This model could use unsupervised learning to identify latent representations that differentiate effective antibiotics from non-effective compounds across different bacterial species. By highlighting subtle molecular differences that correlate with antibiotic potency and spectrum of activity, this approach could prioritize compounds for synthesis and testing that are likely to be effective against resistant bacterial strains.", "best_score_so_far": 0.82, "#explored_so_far": 12, "#cands_this_round": 4}
{"id": "fv9XU7CyN2", "round": 3, "round_best": "Introduce a hierarchical contrastive learning model that processes layers of multimodal molecular data, beginning with basic chemical structures and advancing through complex metabolic and genomic interactions. This method would progressively refine the feature space, focusing on high-potential antibiotic candidates through a series of nested learning stages, enhancing the precision in predicting efficacy against resistant strains.", "round_best_score": 0.82, "best_so_far": "Develop a contrastive learning framework that integrates multimodal molecular data, including chemical structure, genomic data, and metabolic pathways, to discover novel antibiotic compounds. This model could use unsupervised learning to identify latent representations that differentiate effective antibiotics from non-effective compounds across different bacterial species. By highlighting subtle molecular differences that correlate with antibiotic potency and spectrum of activity, this approach could prioritize compounds for synthesis and testing that are likely to be effective against resistant bacterial strains.", "best_score_so_far": 0.82, "#explored_so_far": 15, "#cands_this_round": 3}
{"id": "fv9XU7CyN2", "round": 4, "round_best": "Enhance the contrastive learning framework with an attention mechanism that focuses on critical regions of the molecular data, such as active sites or known resistance mechanisms, to refine the model's predictions about antibiotic efficacy and resistance profiles.", "round_best_score": 0.72, "best_so_far": "Develop a contrastive learning framework that integrates multimodal molecular data, including chemical structure, genomic data, and metabolic pathways, to discover novel antibiotic compounds. This model could use unsupervised learning to identify latent representations that differentiate effective antibiotics from non-effective compounds across different bacterial species. By highlighting subtle molecular differences that correlate with antibiotic potency and spectrum of activity, this approach could prioritize compounds for synthesis and testing that are likely to be effective against resistant bacterial strains.", "best_score_so_far": 0.82, "#explored_so_far": 18, "#cands_this_round": 3}
{"id": "fv9XU7CyN2", "round": 5, "round_best": "Utilize reinforcement learning in conjunction with the contrastive learning model to actively suggest modifications to molecular structures based on predicted efficacy and resistance profiles. This iterative approach could accelerate the optimization of lead compounds and their progression to clinical trials.", "round_best_score": 0.65, "best_so_far": "Develop a contrastive learning framework that integrates multimodal molecular data, including chemical structure, genomic data, and metabolic pathways, to discover novel antibiotic compounds. This model could use unsupervised learning to identify latent representations that differentiate effective antibiotics from non-effective compounds across different bacterial species. By highlighting subtle molecular differences that correlate with antibiotic potency and spectrum of activity, this approach could prioritize compounds for synthesis and testing that are likely to be effective against resistant bacterial strains.", "best_score_so_far": 0.82, "#explored_so_far": 19, "#cands_this_round": 1}
{"id": "fv9XU7CyN2", "round": 6, "round_best": "Combine the contrastive learning framework with synthetic biology tools to directly engineer bacterial strains or enzymes that could either enhance the efficacy of existing antibiotics or contribute to the synthesis of novel compounds. This biotechnological integration could lead to innovative strategies in combating antibiotic resistance.", "round_best_score": 0.38, "best_so_far": "Develop a contrastive learning framework that integrates multimodal molecular data, including chemical structure, genomic data, and metabolic pathways, to discover novel antibiotic compounds. This model could use unsupervised learning to identify latent representations that differentiate effective antibiotics from non-effective compounds across different bacterial species. By highlighting subtle molecular differences that correlate with antibiotic potency and spectrum of activity, this approach could prioritize compounds for synthesis and testing that are likely to be effective against resistant bacterial strains.", "best_score_so_far": 0.82, "#explored_so_far": 21, "#cands_this_round": 2}
{"id": "fv9XU7CyN2", "round": 8, "round_best": "Establish a transfer learning-based contrastive framework that leverages pre-trained models on vast biological datasets before fine-tuning on specific antibiotic-related tasks using multimodal molecular data. This method could accelerate the learning process and improve the model's ability to generalize from known antibiotics to novel compounds.", "round_best_score": 0.78, "best_so_far": "Develop a contrastive learning framework that integrates multimodal molecular data, including chemical structure, genomic data, and metabolic pathways, to discover novel antibiotic compounds. This model could use unsupervised learning to identify latent representations that differentiate effective antibiotics from non-effective compounds across different bacterial species. By highlighting subtle molecular differences that correlate with antibiotic potency and spectrum of activity, this approach could prioritize compounds for synthesis and testing that are likely to be effective against resistant bacterial strains.", "best_score_so_far": 0.82, "#explored_so_far": 23, "#cands_this_round": 2}
{"id": "fv9XU7CyN2", "round": 9, "round_best": "Incorporate a transfer learning approach to the contrastive learning framework, leveraging pre-trained models on related tasks such as enzyme inhibition prediction, to improve the speed and accuracy of identifying potential antibiotic compounds from multimodal molecular data.", "round_best_score": 0.68, "best_so_far": "Develop a contrastive learning framework that integrates multimodal molecular data, including chemical structure, genomic data, and metabolic pathways, to discover novel antibiotic compounds. This model could use unsupervised learning to identify latent representations that differentiate effective antibiotics from non-effective compounds across different bacterial species. By highlighting subtle molecular differences that correlate with antibiotic potency and spectrum of activity, this approach could prioritize compounds for synthesis and testing that are likely to be effective against resistant bacterial strains.", "best_score_so_far": 0.82, "#explored_so_far": 25, "#cands_this_round": 2}
{"id": "fv9XU7CyN2", "round": 10, "round_best": "Utilize active learning methodologies to selectively sample the most informative multimodal data points for training the contrastive learning model. This could improve model efficiency and effectiveness by focusing on data that most significantly impacts learning outcomes.", "round_best_score": 0.35, "best_so_far": "Develop a contrastive learning framework that integrates multimodal molecular data, including chemical structure, genomic data, and metabolic pathways, to discover novel antibiotic compounds. This model could use unsupervised learning to identify latent representations that differentiate effective antibiotics from non-effective compounds across different bacterial species. By highlighting subtle molecular differences that correlate with antibiotic potency and spectrum of activity, this approach could prioritize compounds for synthesis and testing that are likely to be effective against resistant bacterial strains.", "best_score_so_far": 0.82, "#explored_so_far": 26, "#cands_this_round": 1}
{"id": "fv9XU7CyN2", "round": 11, "round_best": "Incorporate advanced natural language processing techniques to analyze scientific literature and patents as an additional data mode in the contrastive learning framework. This could uncover hidden relationships and previously overlooked molecular compounds that could be repurposed as effective antibiotics.", "round_best_score": 0.45, "best_so_far": "Develop a contrastive learning framework that integrates multimodal molecular data, including chemical structure, genomic data, and metabolic pathways, to discover novel antibiotic compounds. This model could use unsupervised learning to identify latent representations that differentiate effective antibiotics from non-effective compounds across different bacterial species. By highlighting subtle molecular differences that correlate with antibiotic potency and spectrum of activity, this approach could prioritize compounds for synthesis and testing that are likely to be effective against resistant bacterial strains.", "best_score_so_far": 0.82, "#explored_so_far": 28, "#cands_this_round": 2}
{"id": "fv9XU7CyN2", "round": 12, "round_best": "Introduce a dynamic weighting scheme in the contrastive learning model that adjusts the importance of different modalities (chemical structure, genomic data, metabolic pathways) based on their predictive value for antibiotic efficacy, enhancing the model's ability to focus on the most informative features for distinguishing between effective and non-effective compounds.", "round_best_score": 0.68, "best_so_far": "Develop a contrastive learning framework that integrates multimodal molecular data, including chemical structure, genomic data, and metabolic pathways, to discover novel antibiotic compounds. This model could use unsupervised learning to identify latent representations that differentiate effective antibiotics from non-effective compounds across different bacterial species. By highlighting subtle molecular differences that correlate with antibiotic potency and spectrum of activity, this approach could prioritize compounds for synthesis and testing that are likely to be effective against resistant bacterial strains.", "best_score_so_far": 0.82, "#explored_so_far": 29, "#cands_this_round": 1}
{"id": "fv9XU7CyN2", "round": 13, "round_best": "Develop a hybrid model that combines contrastive learning with reinforcement learning to simulate the environment of bacterial resistance, allowing the model to predict not only the efficacy of antibiotic compounds but also their resistance development pathways.", "round_best_score": 0.55, "best_so_far": "Develop a contrastive learning framework that integrates multimodal molecular data, including chemical structure, genomic data, and metabolic pathways, to discover novel antibiotic compounds. This model could use unsupervised learning to identify latent representations that differentiate effective antibiotics from non-effective compounds across different bacterial species. By highlighting subtle molecular differences that correlate with antibiotic potency and spectrum of activity, this approach could prioritize compounds for synthesis and testing that are likely to be effective against resistant bacterial strains.", "best_score_so_far": 0.82, "#explored_so_far": 30, "#cands_this_round": 1}
{"id": "fv9XU7CyN2", "round": 14, "round_best": "Utilize advanced pre-training techniques, such as masked language modeling on molecular sequences, before applying contrastive learning. This could enrich the model's initial understanding of molecular structures and functions, potentially leading to more effective identification of novel antibiotics.", "round_best_score": 0.62, "best_so_far": "Develop a contrastive learning framework that integrates multimodal molecular data, including chemical structure, genomic data, and metabolic pathways, to discover novel antibiotic compounds. This model could use unsupervised learning to identify latent representations that differentiate effective antibiotics from non-effective compounds across different bacterial species. By highlighting subtle molecular differences that correlate with antibiotic potency and spectrum of activity, this approach could prioritize compounds for synthesis and testing that are likely to be effective against resistant bacterial strains.", "best_score_so_far": 0.82, "#explored_so_far": 32, "#cands_this_round": 2}
{"id": "fv9XU7CyN2", "round": 15, "round_best": "Utilize advanced visualization techniques in conjunction with the contrastive learning model to create interpretable maps of molecular data, aiding researchers in understanding how different data modalities contribute to predictions.", "round_best_score": 0.45, "best_so_far": "Develop a contrastive learning framework that integrates multimodal molecular data, including chemical structure, genomic data, and metabolic pathways, to discover novel antibiotic compounds. This model could use unsupervised learning to identify latent representations that differentiate effective antibiotics from non-effective compounds across different bacterial species. By highlighting subtle molecular differences that correlate with antibiotic potency and spectrum of activity, this approach could prioritize compounds for synthesis and testing that are likely to be effective against resistant bacterial strains.", "best_score_so_far": 0.82, "#explored_so_far": 35, "#cands_this_round": 3}
{"id": "fv9XU7CyN2", "round": 16, "round_best": "Expand the dataset used in the contrastive learning framework to include ethnopharmacological data, capturing insights from traditional medicine practices. This could uncover novel molecular scaffolds and combinations that have been overlooked in conventional screens, diversifying the pool of potential antibiotic candidates.", "round_best_score": 0.45, "best_so_far": "Develop a contrastive learning framework that integrates multimodal molecular data, including chemical structure, genomic data, and metabolic pathways, to discover novel antibiotic compounds. This model could use unsupervised learning to identify latent representations that differentiate effective antibiotics from non-effective compounds across different bacterial species. By highlighting subtle molecular differences that correlate with antibiotic potency and spectrum of activity, this approach could prioritize compounds for synthesis and testing that are likely to be effective against resistant bacterial strains.", "best_score_so_far": 0.82, "#explored_so_far": 36, "#cands_this_round": 1}
{"id": "fv9XU7CyN2", "round": 17, "round_best": "Explore the integration of patient-derived bacterial isolates and clinical outcome data into the contrastive learning model to tailor antibiotic discovery towards pathogens with high clinical relevance and patient-specific resistance patterns. This personalized approach could help in designing antibiotics that are effective against bacteria with specific resistance mechanisms.", "round_best_score": 0.45, "best_so_far": "Develop a contrastive learning framework that integrates multimodal molecular data, including chemical structure, genomic data, and metabolic pathways, to discover novel antibiotic compounds. This model could use unsupervised learning to identify latent representations that differentiate effective antibiotics from non-effective compounds across different bacterial species. By highlighting subtle molecular differences that correlate with antibiotic potency and spectrum of activity, this approach could prioritize compounds for synthesis and testing that are likely to be effective against resistant bacterial strains.", "best_score_so_far": 0.82, "#explored_so_far": 38, "#cands_this_round": 2}
{"id": "fv9XU7CyN2", "round": 18, "round_best": "Develop a multimodal fusion technique within the contrastive learning framework to better handle and integrate heterogeneous data types, using advanced algorithms to weigh the importance of each data type dynamically. This could lead to more robust models that adaptively focus on the most predictive features for antibiotic efficacy.", "round_best_score": 0.82, "best_so_far": "Develop a contrastive learning framework that integrates multimodal molecular data, including chemical structure, genomic data, and metabolic pathways, to discover novel antibiotic compounds. This model could use unsupervised learning to identify latent representations that differentiate effective antibiotics from non-effective compounds across different bacterial species. By highlighting subtle molecular differences that correlate with antibiotic potency and spectrum of activity, this approach could prioritize compounds for synthesis and testing that are likely to be effective against resistant bacterial strains.", "best_score_so_far": 0.82, "#explored_so_far": 39, "#cands_this_round": 1}
{"id": "fv9XU7CyN2", "round": 20, "round_best": "Integrate a temporal dimension into the multimodal contrastive learning framework to track the evolution of bacterial resistance. By analyzing how the molecular signatures of resistance change over time, the model could predict future resistance patterns and identify novel antibiotic compounds that are likely to remain effective.", "round_best_score": 0.45, "best_so_far": "Develop a contrastive learning framework that integrates multimodal molecular data, including chemical structure, genomic data, and metabolic pathways, to discover novel antibiotic compounds. This model could use unsupervised learning to identify latent representations that differentiate effective antibiotics from non-effective compounds across different bacterial species. By highlighting subtle molecular differences that correlate with antibiotic potency and spectrum of activity, this approach could prioritize compounds for synthesis and testing that are likely to be effective against resistant bacterial strains.", "best_score_so_far": 0.82, "#explored_so_far": 41, "#cands_this_round": 2}
{"id": "fv9XU7CyN2", "round": 21, "round_best": "Implement active learning strategies in the contrastive learning framework to iteratively query the most informative and diverse molecular configurations. This could enhance the efficiency of the discovery process by focusing resources on synthesizing and testing the most promising compounds.", "round_best_score": 0.45, "best_so_far": "Develop a contrastive learning framework that integrates multimodal molecular data, including chemical structure, genomic data, and metabolic pathways, to discover novel antibiotic compounds. This model could use unsupervised learning to identify latent representations that differentiate effective antibiotics from non-effective compounds across different bacterial species. By highlighting subtle molecular differences that correlate with antibiotic potency and spectrum of activity, this approach could prioritize compounds for synthesis and testing that are likely to be effective against resistant bacterial strains.", "best_score_so_far": 0.82, "#explored_so_far": 43, "#cands_this_round": 2}
{"id": "fv9XU7CyN2", "round": 22, "round_best": "Introduce a hierarchical contrastive learning model that processes layers of molecular data, starting from atomic interactions up to complex metabolic pathways, to enhance the detection of potential antibiotic properties. This structured approach could allow for more precise identification of key features that govern antibiotic effectiveness, facilitating targeted drug design.", "round_best_score": 0.82, "best_so_far": "Develop a contrastive learning framework that integrates multimodal molecular data, including chemical structure, genomic data, and metabolic pathways, to discover novel antibiotic compounds. This model could use unsupervised learning to identify latent representations that differentiate effective antibiotics from non-effective compounds across different bacterial species. By highlighting subtle molecular differences that correlate with antibiotic potency and spectrum of activity, this approach could prioritize compounds for synthesis and testing that are likely to be effective against resistant bacterial strains.", "best_score_so_far": 0.82, "#explored_so_far": 44, "#cands_this_round": 1}
{"id": "fv9XU7CyN2", "round": 24, "round_best": "Implement a hierarchical contrastive learning model that processes multimodal molecular data in stages, beginning with chemical structures, then integrating genomic and metabolic data. This staged approach could enhance the specificity of the learned representations, potentially improving the model's ability to pinpoint promising antibiotic candidates against specific resistance mechanisms.", "round_best_score": 0.72, "best_so_far": "Develop a contrastive learning framework that integrates multimodal molecular data, including chemical structure, genomic data, and metabolic pathways, to discover novel antibiotic compounds. This model could use unsupervised learning to identify latent representations that differentiate effective antibiotics from non-effective compounds across different bacterial species. By highlighting subtle molecular differences that correlate with antibiotic potency and spectrum of activity, this approach could prioritize compounds for synthesis and testing that are likely to be effective against resistant bacterial strains.", "best_score_so_far": 0.82, "#explored_so_far": 45, "#cands_this_round": 1}
{"id": "fv9XU7CyN2", "round": 25, "round_best": "Apply a hierarchical contrastive learning approach that first separates compounds into broad classes based on known mechanisms of action and then fine-tunes the representation within these classes to uncover novel compounds with unique properties.", "round_best_score": 0.55, "best_so_far": "Develop a contrastive learning framework that integrates multimodal molecular data, including chemical structure, genomic data, and metabolic pathways, to discover novel antibiotic compounds. This model could use unsupervised learning to identify latent representations that differentiate effective antibiotics from non-effective compounds across different bacterial species. By highlighting subtle molecular differences that correlate with antibiotic potency and spectrum of activity, this approach could prioritize compounds for synthesis and testing that are likely to be effective against resistant bacterial strains.", "best_score_so_far": 0.82, "#explored_so_far": 46, "#cands_this_round": 1}
{"id": "fv9XU7CyN2", "round": 26, "round_best": "Implement an ensemble of contrastive learning models, each trained on different subsets of the multimodal molecular data, to capture diverse aspects of antibiotic efficacy. Combining the insights from these models could lead to a more comprehensive understanding of what constitutes effective antibiotic activity.", "round_best_score": 0.82, "best_so_far": "Develop a contrastive learning framework that integrates multimodal molecular data, including chemical structure, genomic data, and metabolic pathways, to discover novel antibiotic compounds. This model could use unsupervised learning to identify latent representations that differentiate effective antibiotics from non-effective compounds across different bacterial species. By highlighting subtle molecular differences that correlate with antibiotic potency and spectrum of activity, this approach could prioritize compounds for synthesis and testing that are likely to be effective against resistant bacterial strains.", "best_score_so_far": 0.82, "#explored_so_far": 47, "#cands_this_round": 1}
{"id": "fv9XU7CyN2", "round": 28, "round_best": "Implement a modular contrastive learning framework that allows for the easy integration of new types of molecular data as they become available, ensuring that the model remains adaptable and up-to-date with the latest scientific discoveries and technological advancements.", "round_best_score": 0.65, "best_so_far": "Develop a contrastive learning framework that integrates multimodal molecular data, including chemical structure, genomic data, and metabolic pathways, to discover novel antibiotic compounds. This model could use unsupervised learning to identify latent representations that differentiate effective antibiotics from non-effective compounds across different bacterial species. By highlighting subtle molecular differences that correlate with antibiotic potency and spectrum of activity, this approach could prioritize compounds for synthesis and testing that are likely to be effective against resistant bacterial strains.", "best_score_so_far": 0.82, "#explored_so_far": 48, "#cands_this_round": 1}
{"id": "fv9XU7CyN2", "round": 30, "round_best": "Utilize the contrastive learning framework to conduct virtual high-throughput screening of vast chemical libraries, accelerating the identification of novel compounds by efficiently narrowing down the search space to the most promising candidates based on their predicted molecular interactions and efficacy profiles.", "round_best_score": 0.62, "best_so_far": "Develop a contrastive learning framework that integrates multimodal molecular data, including chemical structure, genomic data, and metabolic pathways, to discover novel antibiotic compounds. This model could use unsupervised learning to identify latent representations that differentiate effective antibiotics from non-effective compounds across different bacterial species. By highlighting subtle molecular differences that correlate with antibiotic potency and spectrum of activity, this approach could prioritize compounds for synthesis and testing that are likely to be effective against resistant bacterial strains.", "best_score_so_far": 0.82, "#explored_so_far": 50, "#cands_this_round": 2}
{"id": "fv9XU7CyN2", "round": 31, "round_best": "Develop an interactive platform based on the contrastive learning framework that allows researchers to input hypothetical modifications to molecular structures and predict their impact on antibiotic activity. This tool could accelerate the iterative process of drug design by providing immediate feedback on potential modifications.", "round_best_score": 0.55, "best_so_far": "Develop a contrastive learning framework that integrates multimodal molecular data, including chemical structure, genomic data, and metabolic pathways, to discover novel antibiotic compounds. This model could use unsupervised learning to identify latent representations that differentiate effective antibiotics from non-effective compounds across different bacterial species. By highlighting subtle molecular differences that correlate with antibiotic potency and spectrum of activity, this approach could prioritize compounds for synthesis and testing that are likely to be effective against resistant bacterial strains.", "best_score_so_far": 0.82, "#explored_so_far": 52, "#cands_this_round": 2}
{"id": "fv9XU7CyN2", "round": 32, "round_best": "Explore the use of a dynamic contrastive learning framework where the model adapts its focus on different modalities (chemical, genomic, metabolic) based on the stage of drug development. This could improve model performance by dynamically adjusting to the most relevant features at different phases of the discovery process, from initial screening to final testing.", "round_best_score": 0.68, "best_so_far": "Develop a contrastive learning framework that integrates multimodal molecular data, including chemical structure, genomic data, and metabolic pathways, to discover novel antibiotic compounds. This model could use unsupervised learning to identify latent representations that differentiate effective antibiotics from non-effective compounds across different bacterial species. By highlighting subtle molecular differences that correlate with antibiotic potency and spectrum of activity, this approach could prioritize compounds for synthesis and testing that are likely to be effective against resistant bacterial strains.", "best_score_so_far": 0.82, "#explored_so_far": 53, "#cands_this_round": 1}
{"id": "fv9XU7CyN2", "round": 34, "round_best": "Utilize advanced data augmentation techniques to artificially expand the multimodal datasets, enhancing the robustness and generalizability of the contrastive learning model. Techniques such as generative adversarial networks could be employed to create synthetic molecular profiles that help the model learn more comprehensive representations.", "round_best_score": 0.45, "best_so_far": "Develop a contrastive learning framework that integrates multimodal molecular data, including chemical structure, genomic data, and metabolic pathways, to discover novel antibiotic compounds. This model could use unsupervised learning to identify latent representations that differentiate effective antibiotics from non-effective compounds across different bacterial species. By highlighting subtle molecular differences that correlate with antibiotic potency and spectrum of activity, this approach could prioritize compounds for synthesis and testing that are likely to be effective against resistant bacterial strains.", "best_score_so_far": 0.82, "#explored_so_far": 54, "#cands_this_round": 1}
{"id": "fv9XU7CyN2", "round": 35, "round_best": "Utilize domain adaptation techniques in the contrastive learning framework to address the challenge of data heterogeneity across different bacterial species, improving the robustness and applicability of the model in real-world antibiotic discovery.", "round_best_score": 0.55, "best_so_far": "Develop a contrastive learning framework that integrates multimodal molecular data, including chemical structure, genomic data, and metabolic pathways, to discover novel antibiotic compounds. This model could use unsupervised learning to identify latent representations that differentiate effective antibiotics from non-effective compounds across different bacterial species. By highlighting subtle molecular differences that correlate with antibiotic potency and spectrum of activity, this approach could prioritize compounds for synthesis and testing that are likely to be effective against resistant bacterial strains.", "best_score_so_far": 0.82, "#explored_so_far": 56, "#cands_this_round": 2}
{"id": "fv9XU7CyN2", "round": 39, "round_best": "Utilize quantum machine learning techniques in processing multimodal molecular data to potentially uncover patterns and relationships at a quantum chemical level that classical algorithms might miss. This novel approach could lead to breakthroughs in identifying fundamentally new types of antibiotic compounds.", "round_best_score": 0.45, "best_so_far": "Develop a contrastive learning framework that integrates multimodal molecular data, including chemical structure, genomic data, and metabolic pathways, to discover novel antibiotic compounds. This model could use unsupervised learning to identify latent representations that differentiate effective antibiotics from non-effective compounds across different bacterial species. By highlighting subtle molecular differences that correlate with antibiotic potency and spectrum of activity, this approach could prioritize compounds for synthesis and testing that are likely to be effective against resistant bacterial strains.", "best_score_so_far": 0.82, "#explored_so_far": 57, "#cands_this_round": 1}
{"id": "fv9XU7CyN2", "round": 40, "round_best": "Expand the model to include a broader range of bacterial targets and resistance mechanisms by integrating diverse datasets from multiple sources, including clinical isolate sequences and pharmacokinetic/pharmacodynamic data. This comprehensive approach could help in discovering broad-spectrum antibiotics or targeting specific resistant strains.", "round_best_score": 0.45, "best_so_far": "Develop a contrastive learning framework that integrates multimodal molecular data, including chemical structure, genomic data, and metabolic pathways, to discover novel antibiotic compounds. This model could use unsupervised learning to identify latent representations that differentiate effective antibiotics from non-effective compounds across different bacterial species. By highlighting subtle molecular differences that correlate with antibiotic potency and spectrum of activity, this approach could prioritize compounds for synthesis and testing that are likely to be effective against resistant bacterial strains.", "best_score_so_far": 0.82, "#explored_so_far": 59, "#cands_this_round": 2}
